9 research outputs found

    Examen general de orina: valor predictivo del análisis fisicoquímico y la necesidad del empleo rutinario de la microscopía

    Get PDF
    Antecedentes: El examen general de orina es uno de los exámenes más solicitados debido a que numerosas patologías pueden manifestarse o ser sospechadas a través del análisis de este espécimen. El análisis básico consiste en una examinación macroscópica, así como la tira reactiva de orina y la evaluación microscópica. El examen microscópico de la orina es conocido por ser la parte que consumen mayor tiempo de preparación y de análisis. Las Guías Europeas de Uroanálisis refieren que la examinación del sedimento urinario ofrece muy poca información adicional luego de una prueba de orina con tira y cuando esta última es negativa para eritrocitos, leucocitos y proteínas, la microscopía del sedimento generalmente no está justificada. Identificar factores en los pacientes y/o en los resultados del análisis de la tira reactiva que ayuden en predecir la mucha o poca utilidad del resultado de la microscopía urinaria en el diagnóstico y tratamiento del paciente, sin poner en riesgo su salud, podría traducirse en una menor inversión de tiempo, costos y claridad en los resultados del estudio. Objetivo General: Determinar si con un resultado negativo o no patológico de la tira reactiva del examen general de orina, junto a factores como edad, sexo y servicio del que proviene la solicitud, es posible omitir el análisis microscópico del estudio, sin que ello comprometa la seguridad de los pacientes. Objetivos Específicos: 1. Comparar los resultados de la tira reactiva con los obtenidos en la microscopía de orina. 2. Identificar las variables que pueden predecir un resultado de microscopía urinaria negativa e identificar en qué pacientes podría omitirse dicho paso en el protocolo de estudio.8 noviembre de 2022 3. Evaluar en los pacientes el riesgo que conlleva a su salud la eliminación del análisis de microscopía urinaria del examen general de orina. Material y Métodos: Fueron analizados de manera retrospectiva los datos registrados de los resultados de exámenes generales de orina obtenidos en el Laboratorio Central del Hospital Universitario “Dr. José E. González” de la Universidad Autónoma de Nuevo León del periodo comprendido del 1 de septiembre de 2021 al 28 de febrero de 2022. Realizamos un análisis descriptivo de las variables de interés del paciente, así como una descripción de proporciones para las variables categóricas nominales y ordinales. Para el análisis de la sensibilidad (Se) y especificidad (Sp) realizamos una tabla de contingencia de 2 por 2 que incluya los resultados de la prueba de la tira reactiva y la microscopía urinaria. La sensibilidad, especificidad, valor predictivo positivo (PPV), valor predictivo negativo (NPV) y tasa de falsos negativos (FNR) serán calculados por medio de límites de confianza binomiales exactos. También realizamos un análisis descriptivo de una matriz de riesgo en porcentajes y también un análisis de regresión logística binaria utilizando como variable dependiente el resultado de la microscopía urinaria en exámenes con resultado de tira reactiva negativo, utilizando variables dependientes de edad, sexo, gravedad específica, proteínas, sangre, nitritos y esterasa leucocitaria. Resultados: Los análisis de tira reactiva y microscópico fueron realizados en los dispositivos Clinitek-ATLAS (prueba índice) e iQ200-SPRINT (estándar de referencia). Los análisis por tira reactiva o microscopía fueron positivos si ≥1 parámetros estaban alterados. 552 pacientes fueron incluidos en el estudio. La mediana posterior a nivel grupo resultó 94% (intervalo credibilidad 95%[CrI95%] 89.9-97%) para Se, 57.1% (CrI95% 50.1-64.1%) para Sp y 5.8% (CrI95% 2.59-9.64%) para FNR. La probabilidad posterior de Se>90% fue del 95.9% a nivel grupal. El análisis de riesgo encontró solo falsos negativos de bajo riesgo. Conclusiones: El rendimiento de la tira reactiva fue adecuado, con buena certeza de sensibilidad >90% y tasa de falsos negativos <10% a nivel operador. La omisión del análisis microscópico puede ser una acción segura en pacientes con tira reactiva negativa, no se esperan falsos negativos con repercusión clínica

    Urinalysis: diagnostic performance of urine dipstick compared to an automated microscopic method

    Get PDF
    Introduction: Urinalysis is one of the most important clinical laboratory tests because numerous pathologies can manifest or be suspected through this test. Although the previous reports mention that urinary microscopy is a fundamental part of urinalysis for diagnostic support of various conditions, there is a debate about the utility of this test section in a certain patient population. The aim of this study was to determine the diagnostic performance of the urinary dipstick analysis and the potential risks of false-negative (FN) results. Material and methods: This is a retrospective and observational study, and urinalysis information was obtained from non-hospitalized patients. The dipstick and microscopic analyses were performed using the Clinitek-ATLAS (index test) and iQ200-SPRINT (reference standard) devices. Dipstick or microscopy analyses were positive if ≥ 1 parameters were abnormal. A Bayesian hierarchal beta-binomial model was carried out for each performance parameter. Risk analysis was performed as proposed in the literature. Results: Five hundred and fifty-two patients were included in the study. The posterior median at group level was 94% (credible interval 95% [CrI 95%] 89.9-97%) for sensitivity (Se), 57.1% (CrI 95%, 50.1-64.1%) for specificity, and 5.8% (CrI 95%, 2.59-9.64%) for FN rate (FNR). The posterior probability Se > 90% was 95.9% at a group level. The risk analysis found only low-risk false-negative events. Conclusions: The performance of the dipstick analysis was appropriate, with a good certainty of Se > 90% and a FNR < 10% at the operator level. Omission of microscopic analysis can be a safe action in a patient with a negative dipstick since FNs with a clinical impact are not expected

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Urinalysis: diagnostic performance of urine dipstick compared to an automated microscopic method

    Get PDF
    Introduction: Urinalysis is one of the most important clinical laboratory tests because numerous pathologies can manifest or be suspected through this test. Although the previous reports mention that urinary microscopy is a fundamental part of urinalysis for diagnostic support of various conditions, there is a debate about the utility of this test section in a certain patient population. The aim of this study was to determine the diagnostic performance of the urinary dipstick analysis and the potential risks of false-negative (FN) results. Material and methods: This is a retrospective and observational study, and urinalysis information was obtained from non-hospitalized patients. The dipstick and microscopic analyses were performed using the Clinitek-ATLAS (index test) and iQ200-SPRINT (reference standard) devices. Dipstick or microscopy analyses were positive if ≥ 1 parameters were abnormal. A Bayesian hierarchal beta-binomial model was carried out for each performance parameter. Risk analysis was performed as proposed in the literature. Results: Five hundred and fifty-two patients were included in the study. The posterior median at group level was 94% (credible interval 95% [CrI 95%] 89.9-97%) for sensitivity (Se), 57.1% (CrI 95%, 50.1-64.1%) for specificity, and 5.8% (CrI 95%, 2.59-9.64%) for FN rate (FNR). The posterior probability Se > 90% was 95.9% at a group level. The risk analysis found only low-risk false-negative events. Conclusions: The performance of the dipstick analysis was appropriate, with a good certainty of Se > 90% and a FNR < 10% at the operator level. Omission of microscopic analysis can be a safe action in a patient with a negative dipstick since FNs with a clinical impact are not expected

    Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)

    No full text
    The original version of this article unfortunately contained a mistake. The members of the ESICM Trials Group Collaborators were not shown in the article but only in the ESM. The full list of collaborators is shown below. The original article has been corrected
    corecore